Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pexacerfont in Anxious Alcoholics
NCT01227980Phase 2Completed
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism
- Start
- Oct 2010
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pexacerfont in alcohol dependence, sponsored by National Institute on Alcohol Abuse and Alcoholism. Started Oct 2010; status: completed.
02
Drugs
pexacerfont
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT01227980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01227980.